MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
+13.14%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$247M
AUM Growth
+$247M
(+2%)
Cap. Flow
-$3.56M
Cap. Flow
% of AUM
-1.44%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
HSTO
Histogen Inc. Common Stock
HSTO
|
$2.66M |
| 2 |
PETX
Aratana Therapeutics, Inc.
PETX
|
$900K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rhythm Pharmaceuticals
RYTM
$6.85B
| $67.6M | 27.34% | 3,074,893 | – | – |
|
|
HARP
2
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $58.8M | 23.77% | 4,524,425 | – | – |
|
|
TCRR
3
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $58M | 23.42% | 4,050,865 | – | – |
|
|
CHMA
4
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $42.9M | 17.31% | 5,736,296 | – | – |
|
5
Syndax Pharmaceuticals
SNDX
$1.41B
| $20.2M | 8.16% | 2,168,691 | – | – |
|
|
HSTO
6
DELISTED
Histogen Inc. Common Stock
HSTO
| – | – | -2,464,807 | Closed | -$2.66M |
|
|
PETX
7
DELISTED
Aratana Therapeutics, Inc.
PETX
| – | – | -250,000 | Closed | -$900K |
|